Taking a human-centred approach in using Artificial Intelligence to reimagine medicine.
AI is helping Novartis increase patient access, improve customer experience, drive automation, provide predictive analytics and detect potential misconduct. It also has the potential to be used to improve the speed and accuracy of diagnosis, treatment protocols, drug discovery, drug development, patient monitoring, and patient care, among other applications that will improve patients’ lives and optimize the healthcare ecosystem.
These technological developments come with both opportunities and challenges, leading to important questions which, as a leading medicines company, we need to address thoughtfully and affirmatively. With AI playing such a critical role in enabling our digital strategy and transformation, we recognize the need to define clear ethical principles around AI. Hence, Novartis is committed to deploying AI systems in a transparent and responsible way. We will ensure that the use of AI systems has a clear purpose, that is respectful of human rights, and is accurate, truthful, not misleading and appropriate for the intended context.
Our principles for ethical use of AI
Novartis believes that any development, application or use of AI systems should be governed within the following ethical principles which are fully aligned to the Novartis Code of Ethics principles and commitments: